1 minute read
MedPharm to invest £1.5m in refurbishment programme
MedPharm, a specialist in formulation development and analytical services for topical and transdermal products, is to invest £1.5m in a refurbishment programme that will increase laboratory space in the UK by 35%.
The renovations will incorporate increased investment in automated technologies and upgrades to its formulation and analytical laboratories, clinical manufacturing suites and personnel workspace.
Scheduled to be completed in November 2021, the increased capacity will help MedPharm to continue meeting the growing demand for its topical and transdermal services.
MedPharm says expanding and reimagining the laboratory space will enable a streamlined workflow that allows its scientists to provide optimal service to its clients for years to come.
Dr Rob Turner, general manager UK of MedPharm, said: “We are excited to be renovating our formulation and analytical laboratories, clinical manufacturing suites and personnel workspace to ensure our operations and capabilities remain state of the art.
“During the renovations, we will take extensive steps to de-risk the process and do not expect any disruption to our existing services, quality of scientific deliverables and client commitments throughout the refurbishment. We have been supporting clients from Guildford for 15 years and this renovation will secure our footprint here in Surrey for years to come.”